Published: 29 May 2020
Author(s): Pau Cerdà, Cecilia Becattini, Adriana Iriarte, Josefina Cortés Hernández, Xavier Corbella, Antoni Riera-Mestre

Anticoagulant treatment is recommended in patients with thrombosis and antiphospholipid syndrome (APS). Conflicting results have been reported on the role of direct oral anticoagulants (DOACs) in these patients. We performed a meta-analysis of randomized controlled trials (RCTs) focused on this issue.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.